{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:55:21Z","timestamp":1791899721019,"version":"4.3.4"},"reference-count":31,"publisher":"Bioscientifica","issue":"10","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parathyroid carcinoma is rare, and its epidemiological relationship to non-cancer primary hyperparathyroidism, along with the comparative long-term cardiometabolic burden of both conditions, remains poorly characterized at the population level. Using the Korea National Health Insurance Service database (2005\u20132020), we identified 296 patients with incident parathyroid carcinoma and 6,837 patients with non-cancer primary hyperparathyroidism, compared against 71,330 age- and sex-matched controls from the general population. Over the study period, the annual incidence of non-cancer primary hyperparathyroidism increased 7.7-fold, while that of parathyroid carcinoma rose 5.0-fold; because benign disease expanded more rapidly, the proportional contribution of carcinoma among all primary hyperparathyroidism cases declined from 6.67% (2006\u20132010) to 4.06% (2016\u20132020). Survival analysis demonstrated that both parathyroid carcinoma (adjusted hazard ratio: 2.29; 95% confidence interval: 1.53\u20133.43) and non-cancer primary hyperparathyroidism (adjusted hazard ratio: 1.22; 95% confidence interval: 1.09\u20131.35) were associated with significantly higher 10-year all-cause mortality than matched controls, with mortality risk markedly greater in the carcinoma group. Both parathyroid conditions also conferred modestly elevated risks of subsequent incident cardiometabolic complications, including atherosclerotic cardiovascular disease and new-onset type 2 diabetes mellitus. These findings document a rising burden of parathyroid disease in Korea and underscore the need for cardiometabolic risk surveillance in patients with both malignant and benign parathyroid disorders.<\/jats:p>","DOI":"10.1530\/erc-26-0259","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:11:38Z","timestamp":1790169098000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["Parathyroid carcinoma and primary hyperparathyroidism: trends and outcomes"],"prefix":"10.1530","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9271-4802","authenticated-orcid":true,"given":"Seungjin","family":"Baek","sequence":"first","affiliation":[{"name":"Yonsei University College of Medicine 1 , ,","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Heui","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine 2 , ,","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wook","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei Cancer Center, Yonsei University College of Medicine 3 , ,","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang gon","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine 4 , ,","place":["Seoul, Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-young","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine 5 , ,","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milim","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yonsei University College of Medicine 6 , ,","place":["Seoul, Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-5638","authenticated-orcid":true,"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine 2 , ,","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4155-6035","authenticated-orcid":true,"given":"Jong Ju","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei Cancer Center, Yonsei University College of Medicine 3 , ,","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8246-1956","authenticated-orcid":true,"given":"Namki","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine 2 , ,","place":["Seoul, Republic of Korea"]},{"name":"Yonsei Institute for Digital Health, Yonsei University 7 , ,","place":["Seoul, South Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"2026101309413680400_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.otohns.2004.10.005","article-title":"A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003","volume":"132","author":"Ruda","year":"2005","journal-title":"Otolaryngology-Head Neck Surg"},{"key":"2026101309413680400_bib2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.clon.2010.04.007","article-title":"Parathyroid carcinoma","volume":"22","author":"Givi","year":"2010","journal-title":"Clin Oncol"},{"key":"2026101309413680400_bib3","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0287","article-title":"Diagnosis and management of parathyroid carcinoma: a state-of-the-art review","volume":"30","author":"Roser","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"2026101309413680400_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965\u20132010)","volume":"73","author":"Griebeler","year":"2015","journal-title":"Bone"},{"key":"2026101309413680400_bib5","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026101309413680400_bib6","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/cancers11111676","article-title":"Parathyroid cancer: a review","volume":"11","author":"Machado","year":"2019","journal-title":"Cancers"},{"key":"2026101309413680400_bib7","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid carcinoma: a 43-year outcome and survival analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026101309413680400_bib8","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1245\/s10434-015-4672-3","article-title":"Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the National Cancer Data Base (NCDB)","volume":"22","author":"Asare","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2026101309413680400_bib9","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2020","journal-title":"J Bone Miner Res"},{"key":"2026101309413680400_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","article-title":"Classical complications of primary hyperparathyroidism","volume":"32","author":"Minisola","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"2026101309413680400_bib11","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3390\/cancers14061426","article-title":"Parathyroid carcinoma: incidence, survival analysis, and management: a study from the SEER database and insights into future therapeutic perspectives","volume":"14","author":"Ullah","year":"2022","journal-title":"Cancers"},{"key":"2026101309413680400_bib12","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.22599","article-title":"Trends in the incidence and treatment of parathyroid cancer in the United States","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"2026101309413680400_bib13","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1007\/s00432-021-03576-9","article-title":"Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort","volume":"147","author":"Kong","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"2026101309413680400_bib14","first-page":"799","article-title":"Data resource profile: the national health information database of the National Health Insurance Service in South Korea","volume":"46","author":"Cheol","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2026101309413680400_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziae065","article-title":"Secular trends in the incidence and treatment patterns of primary hyperparathyroidism in Korea: a nationwide cohort study","volume":"8","author":"Kim","year":"2024","journal-title":"JBMR Plus"},{"key":"2026101309413680400_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2026101309413680400_bib17","article-title":"Increasing incidence of primary hyperparathyroidism in Denmark","volume":"60","author":"Abood","year":"2013","journal-title":"Dan Med J"},{"key":"2026101309413680400_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12020-022-03211-8","article-title":"Residual risks of comorbidities after parathyroidectomy in a nationwide cohort of patients with primary hyperparathyroidism","volume":"79","author":"Kong","year":"2022","journal-title":"Endocrine"},{"key":"2026101309413680400_bib19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/0284186X.2017.1306103","article-title":"A nationwide study on parathyroid carcinoma","volume":"56","author":"Ryh\u00e4nen","year":"2017","journal-title":"Acta Oncol"},{"key":"2026101309413680400_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1445-2197.2010.05594.x","article-title":"Parathyroid carcinoma: increasing incidence and changing presentation","volume":"81","author":"Brown","year":"2011","journal-title":"ANZ J Surg"},{"key":"2026101309413680400_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/ije\/9936658","article-title":"Trends in clinical features of primary hyperparathyroidism during 2013-2024","volume":"2026","author":"Chen","year":"2026","journal-title":"Int J Endocrinol"},{"key":"2026101309413680400_bib22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/BF01665308","article-title":"Diagnosis and treatment of patients with parathyroid carcinoma: an update and review","volume":"15","author":"Obara","year":"1991","journal-title":"World J Surg"},{"key":"2026101309413680400_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hed.21716","article-title":"Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma","volume":"34","author":"Kim","year":"2012","journal-title":"Head Neck"},{"key":"2026101309413680400_bib24","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"2026101309413680400_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12022-016-9426-7","article-title":"Role of histological criteria and immunohistochemical markers in predicting risk of malignancy in parathyroid neoplasms","volume":"27","author":"Kumari","year":"2016","journal-title":"Endocr Pathol"},{"key":"2026101309413680400_bib26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"key":"2026101309413680400_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.44623","article-title":"Parathyroidectomy and cardiometabolic risks in patients with primary hyperparathyroidism","volume":"8","author":"Tsur","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026101309413680400_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.surg.2019.05.094","article-title":"Coronary artery disease is more severe in patients with primary hyperparathyroidism","volume":"167","author":"Koubaity","year":"2020","journal-title":"Surgery"},{"key":"2026101309413680400_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12916-023-02946-z","article-title":"Investigating the risk of metabolic and cardiovascular comorbidities among patients with parathyroid cancer: a nationwide representative cohort study in Taiwan","volume":"21","author":"Tsai","year":"2023","journal-title":"BMC Med"},{"key":"2026101309413680400_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3803\/EnM.2021.1061","article-title":"Normocalcemic primary hyperparathyroidism: need for a standardized clinical approach","volume":"36","author":"Zavatta","year":"2021","journal-title":"Endocrinol Metab"},{"key":"2026101309413680400_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3803\/EnM.2017.32.3.339","article-title":"Calcium and cardiovascular disease","volume":"32","author":"Reid","year":"2017","journal-title":"Endocrinol Metab"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-26-0259\/525653\/erc-26-0259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-26-0259\/525653\/erc-26-0259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:41:45Z","timestamp":1791898905000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/10\/e260259\/78255\/Parathyroid-carcinoma-and-primary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-26-0259","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"e260259"}}